Combination therapy for neovascular AMD: Could the combination of an anti-VEGF agent and an anti-PDGF drug solve some of the issues seen with anti-VEGF monotherapy? Trial data may soon tell
Publication
, Journal Article
Jaffe, GJ
Published in: Retina Today
July 1, 2016
Duke Scholars
Published In
Retina Today
EISSN
1825-0572
Publication Date
July 1, 2016
Volume
2016July-August
Start / End Page
88 / 91
Citation
APA
Chicago
ICMJE
MLA
NLM
Jaffe, G. J. (2016). Combination therapy for neovascular AMD: Could the combination of an anti-VEGF agent and an anti-PDGF drug solve some of the issues seen with anti-VEGF monotherapy? Trial data may soon tell. Retina Today, 2016July-August, 88–91.
Jaffe, G. J. “Combination therapy for neovascular AMD: Could the combination of an anti-VEGF agent and an anti-PDGF drug solve some of the issues seen with anti-VEGF monotherapy? Trial data may soon tell.” Retina Today 2016July-August (July 1, 2016): 88–91.
Jaffe GJ. Combination therapy for neovascular AMD: Could the combination of an anti-VEGF agent and an anti-PDGF drug solve some of the issues seen with anti-VEGF monotherapy? Trial data may soon tell. Retina Today. 2016 Jul 1;2016July-August:88–91.
Jaffe, G. J. “Combination therapy for neovascular AMD: Could the combination of an anti-VEGF agent and an anti-PDGF drug solve some of the issues seen with anti-VEGF monotherapy? Trial data may soon tell.” Retina Today, vol. 2016July-August, July 2016, pp. 88–91.
Jaffe GJ. Combination therapy for neovascular AMD: Could the combination of an anti-VEGF agent and an anti-PDGF drug solve some of the issues seen with anti-VEGF monotherapy? Trial data may soon tell. Retina Today. 2016 Jul 1;2016July-August:88–91.
Published In
Retina Today
EISSN
1825-0572
Publication Date
July 1, 2016
Volume
2016July-August
Start / End Page
88 / 91